Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Durantel

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Plos One|October 15, 2024
The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNAFlorentin Pastor, Emilie Charles, Chiara Di Vona, et al.
Journal of Hepatology|December 4, 2003
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patientJean-Pierre Villeneuve, David Durantel, Sandra Durantel, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2006
Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon systemVanessa Escuret, Amaury Martin, David Durantel, et al.
Gut|May 22, 2021
RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytesJiazeng Sun, Guanhui Wu, Florentin Pastor, et al.
Theranostics|October 12, 2020
Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinomaSaravana Kumar Kailasam Mani, Bingyu Yan, Zhibin Cui, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic CellsLudovic Aillot, Marc Bonnin, Malika Ait-Goughoulte, et al.
Hepatology Communications|April 14, 2023
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivityAnne-Flore Legrand, Julie Lucifora, Benoît Lacombe, et al.
Clinical & Translational Immunology|December 14, 2020
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCsLaurissa Ouaguia, Tania Dufeu-Duchesne, Vincent Leroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2018
Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B CellsIssam Tout, Melissa Gomes, Michelle Ainouze, et al.
Antiviral Research|August 8, 2018
Meeting report: 31<sup>st</sup> International Conference on Antiviral ResearchMike Bray, Graciela Andrei, Ester Ballana, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Plos One|October 15, 2024
The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNAFlorentin Pastor, Emilie Charles, Chiara Di Vona, et al.
Journal of Hepatology|December 4, 2003
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patientJean-Pierre Villeneuve, David Durantel, Sandra Durantel, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2006
Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon systemVanessa Escuret, Amaury Martin, David Durantel, et al.
Gut|May 22, 2021
RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytesJiazeng Sun, Guanhui Wu, Florentin Pastor, et al.
Theranostics|October 12, 2020
Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinomaSaravana Kumar Kailasam Mani, Bingyu Yan, Zhibin Cui, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic CellsLudovic Aillot, Marc Bonnin, Malika Ait-Goughoulte, et al.
Hepatology Communications|April 14, 2023
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivityAnne-Flore Legrand, Julie Lucifora, Benoît Lacombe, et al.
Clinical & Translational Immunology|December 14, 2020
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCsLaurissa Ouaguia, Tania Dufeu-Duchesne, Vincent Leroy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2018
Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B CellsIssam Tout, Melissa Gomes, Michelle Ainouze, et al.
Antiviral Research|August 8, 2018
Meeting report: 31<sup>st</sup> International Conference on Antiviral ResearchMike Bray, Graciela Andrei, Ester Ballana, et al.
Pageof 13